SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-037072
Filing Date
2018-06-11
Accepted
2018-06-11 18:09:45
Documents
1
Period of Report
2018-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1631
  Complete submission text file 0001209191-18-037072.txt   3267
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
O'Neill Gilmore Neil (Reporting) CIK: 0001742084 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14895 | Film No.: 18893093